Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes

Frontiers in Molecular Neuroscience

Volumn 9, Issue FEB, 2016, Pages

  von Jonquieres, Georg ^a   Fröhlich, Dominik ^a   Klugmann, Claudia B ^a   Wen, Xin ^a   Harasta, Anne E ^a   Ramkumar, Roshini ^a   Spencer, Ziggy H T ^a   Housley, Gary D ^a   Klugmann, Matthias ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AAV; Gene therapy; Leukodystrophy; Myelin associated glycoprotein; Oligodendroglia; White matter disorders

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM FUNCTION; GENE EXPRESSION; GENE THERAPY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKODYSTROPHY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PLASMID; QUANTITATIVE ANALYSIS; STRUCTURAL BIOINFORMATICS; TRANSCRIPTION REGULATION; TRANSGENE EXPRESSION;

EID: 84961734853     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00013     Document Type: Article

References (45)

1. Ahmed, S. S. Li, H. Cao, C. Sikoglu, E. M. Denninger, A. R. Su, Q. et al. (2013). A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS gene therapy in Canavan mice. Mol. Ther. 21, 2136-2147. doi: 10. 1038/mt. 2013. 138
2. Biffi, A. Montini, E. Lorioli, L. Cesani, M. Fumagalli, F. Plati, T. et al. (2013). Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158. doi: 10. 1126/science. 1233158
3. Bujalka, H. Koenning, M. Jackson, S. Perreau, V. M. Pope, B. Hay, C. M. et al. (2013). MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol. 11:e1001625. doi: 10. 1371/journal. pbio. 1001625
4. Cahoy, J. D. Emery, B. Kaushal, A. Foo, L. C. Zamanian, J. L. Christopherson, K. S. et al. (2008). A transcriptome database for astrocytes, neurons and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278. doi: 10. 1523/JNEUROSCI. 4178-07. 2008
5. Cartier, N. Hacein-Bey-Abina, S. Bartholomae, C. C. Veres, G. Schmidt, M. Kutschera, I. et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818-823. doi: 10. 1126/science. 1171242
6. Chen, H. McCarty, D. M. Bruce, A. T. and Suzuki, K. (1998). Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther. 5, 50-58. doi: 10. 1038/sj. gt. 3300547
7. Clancy, B. Darlington, R. B. and Finlay, B. L. (2001). Translating developmental time across mammalian species. Neuroscience 105, 7-17. doi: 10. 1016/s0306-4522(01)00171-3
8. Dayton, R. D. Wang, D. B. and Klein, R. L. (2012). The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin. Biol. Ther. 12, 757-766. doi: 10. 1517/14712598. 2012. 681463
9. Dong, J. Y. Fan, P. D. and Frizzell, R. A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene. Ther. 7, 2101-2112. doi: 10. 1089/hum. 1996. 7. 17-2101
10. During, M. J. Young, D. Baer, K. Lawlor, P. and Klugmann, M. (2003). Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods Mol. Med. 76, 221-236. doi: 10. 1385/1-59259-304-6:221
11. Emery, B. (2010). Regulation of oligodendrocyte differentiation and myelination. Science 330, 779-782. doi: 10. 1126/science. 1190927
12. Emery, B. Agalliu, D. Cahoy, J. D. Watkins, T. A. Dugas, J. C. Mulinyawe, S. B. et al. (2009). Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138, 172-185. doi: 10. 1016/j. cell. 2009. 04. 031
13. Fitzsimons, H. L. Bland, R. J. and During, M. J. (2002). Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 28, 227-236. doi: 10. 1016/s1046-2023(02)00227-x
14. Frühbeis, C. Frohlich, D. Kuo, W. P. Amphornrat, J. Thilemann, S. Saab, A. S. et al. (2013). Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 11:e1001604. doi: 10. 1371/journal. pbio. 1001604
15. Gao, G. P. Alvira, M. R. Wang, L. Calcedo, R. Johnston, J. and Wilson, J. M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U S A 99, 11854-11859. doi: 10. 1073/pnas. 182412299
16. Gao, G. Vandenberghe, L. H. Alvira, M. R. Lu, Y. Calcedo, R. Zhou, X. et al. (2004). Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. doi: 10. 1128/jvi. 78. 12. 6381-6388. 2004
17. Gow, A. Friedrich, V. L. Jr. and Lazzarini, R. A. (1992). Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J. Cell Biol. 119, 605-616. doi: 10. 1083/jcb. 119. 3. 605
18. Gravel, M. Di Polo, A. Valera, P. B. and Braun, P. E. (1998). Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J. Neurosci. Res. 53, 393-404. doi: 10. 1002/(sici)1097-4547(19980815)53:4<393::aid-jnr1>3. 3. co;2-y
19. Harasta, A. E. Power, J. M. von Jonquieres, G. Karl, T. Drucker, D. J. Housley, G. D. et al. (2015). Septal Glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior. Neuropsychopharmacology 40, 1969-1978. doi: 10. 1038/npp. 2015. 47
20. He, Y. Dupree, J. Wang, J. Sandoval, J. Li, J. Liu, H. et al. (2007). The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55, 217-230. doi: 10. 1016/j. neuron. 2007. 06. 029
21. Hoshikawa, S. Ogata, T. Fujiwara, S. Nakamura, K. and Tanaka, S. (2008). A novel function of RING finger protein 10 in transcriptional regulation of the myelin-associated glycoprotein gene and myelin formation in Schwann cells. PLoS One 3:e3464. doi: 10. 1371/journal. pone. 0003464
22. Kagiava, A. Sargiannidou, I. Bashiardes, S. Richter, J. Schiza, N. Christodoulou, C. et al. (2014). Gene delivery targeted to oligodendrocytes using a lentiviral vector. J. Gene Med. 16, 364-373. doi: 10. 1002/jgm. 2813
23. Kawai, K. Itoh, T. Itoh, A. Horiuchi, M. Wakayama, K. Bannerman, P. et al. (2009). Maintenance of the relative proportion of oligodendrocytes to axons even in the absence of BAX and BAK. Eur. J. Neurosci. 30, 2030-2041. doi: 10. 1111/j. 1460-9568. 2009. 06988. x
24. Klugmann, M. Leichtlein, C. B. Symes, C. W. Serikawa, T. Young, D. and During, M. J. (2005a). Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Mol. Ther. 11, 745-753. doi: 10. 1016/j. ymthe. 2005. 01. 006
25. Klugmann, M. Symes, C. W. Leichtlein, C. B. Klaussner, B. K. Dunning, J. Fong, D. et al. (2005b). AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Mol. Cell. Neurosci. 28, 343-360. doi: 10. 1016/j. mcn. 2004. 10. 002
26. Krämer, E. M. Koch, T. Niehaus, A. and Trotter, J. (1997). Oligodendrocytes direct glycosyl phosphatidylinositol-anchored proteins to the myelin sheath in glycosphingolipid-rich complexes. J. Biol. Chem. 272, 8937-8945. doi: 10. 1074/jbc. 272. 14. 8937
27. Lawlor, P. A. Bland, R. J. Mouravlev, A. Young, D. and During, M. J. (2009). Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol. Ther. 17, 1692-1702. doi: 10. 1038/mt. 2009. 170
28. Leone, P. Shera, D. McPhee, S. W. Francis, J. S. Kolodny, E. H. Bilaniuk, L. T. et al. (2012). Long-term follow-up after gene therapy for canavan disease. Sci. Transl. Med. 4:165ra163. doi: 10. 1126/scitranslmed. 3003454
29. Marin-Husstege, M. He, Y. Li, J. Kondo, T. Sablitzky, F. and Casaccia-Bonnefil, P. (2006). Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings. Glia 54, 285-296. doi: 10. 1002/glia. 20385
30. Martini, R. and Schachner, M. (1997). Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19, 298-310. doi: 10. 1002/(sici)1098-1136(199704)19:4<298::aid-glia3>3. 3. co;2-l
31. Mathis, C. Hindelang, C. LeMeur, M. and Borrelli, E. (2000). A transgenic mouse model for inducible and reversible dysmyelination. J. Neurosci. 20, 7698-7705.
32. McCarty, D. M. (2008). Self-complementary AAV vectors; advances and applications. Mol. Ther. 16, 1648-1656. doi: 10. 1038/mt. 2008. 171
33. McClure, C. Cole, K. L. Wulff, P. Klugmann, M. and Murray, A. J. (2011). Production and titering of recombinant adeno-associated viral vectors. J. Vis. Exp. 57:e3348. doi: 10. 3791/3348
34. Mersmann, N. Tkachev, D. Jelinek, R. Roth, P. T. Mobius, W. Ruhwedel, T. et al. (2011). Aspartoacylase-LacZ Knockin mice: an engineered model of canavan disease. PLoS One 6:e20336. doi: 10. 1371/journal. pone. 0020336
35. Mingorance, A. Fontana, X. Soriano, E. and Del Rio, J. A. (2005). Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway. Mol. Cell. Neurosci. 29, 471-483. doi: 10. 1016/j. mcn. 2005. 03. 016
36. Orian, J. M. Mitchell, A. W. Marshman, W. E. Webb, G. C. Ayers, M. M. Grail, D. et al. (1994). Insertional mutagenesis inducing hypomyelination in transgenic mice. J. Neurosci. Res. 39, 604-612. doi: 10. 1002/jnr. 490390512
37. Pilpel, N. Landeck, N. Klugmann, M. Seeburg, P. H. and Schwarz, M. K. (2009). Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. J. Neurosci. Methods 182, 55-63. doi: 10. 1016/j. jneumeth. 2009. 05. 020
38. Thoms, J. A. Birger, Y. Foster, S. Knezevic, K. Kirschenbaum, Y. Chandrakanthan, V. et al. (2011). ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer. Blood 117, 7079-7089. doi: 10. 1182/blood-2010-12-317990
39. von Jonquieres, G. Froud, K. E. Klugmann, C. B. Wong, A. C. Housley, G. D. and Klugmann, M. (2014). Loss of central auditory processing in a mouse model of Canavan disease. PLoS One 9:e97374. doi: 10. 1371/journal. pone. 0097374
40. von Jonquieres, G. Mersmann, N. Klugmann, C. B. Harasta, A. E. Lutz, B. Teahan, O. et al. (2013). Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One 8:e65646. doi: 10. 1371/journal. pone. 0065646
41. Wang, J. Pol, S. U. Haberman, A. K. Wang, C. O'Bara, M. A. and Sim, F. J. (2014). Transcription factor induction of human oligodendrocyte progenitor fate and differentiation. Proc. Natl. Acad. Sci. U S A 111, E2885-E2894. doi: 10. 1073/pnas. 1408295111
42. Warrington, K. H. Jr. and Herzog, R. W. (2006). Treatment of human disease by adeno-associated viral gene transfer. Hum. Genet. 119, 571-603. doi: 10. 1007/s00439-006-0165-6
43. Weinberg, M. S. Samulski, R. J. and McCown, T. J. (2013). Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 69, 82-88. doi: 10. 1016/j. neuropharm. 2012. 03. 004
44. Xiao, P. J. Li, C. Neumann, A. and Samulski, R. J. (2012). Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues. Mol. Ther. 20, 317-328. doi: 10. 1038/mt. 2011. 250
45. Zolova, O. E. and Wight, P. A. (2011). YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells. ASN Neuro 3:e00067. doi: 10. 1042/AN20110021